'Blue-sky' oyster vaccine has global potential say scientists

'Blue-sky' oyster vaccine has global potential say scientists
The Pacific oyster industry has struggled with a deadly virus since 2010. (Image: Moana NZ)
Greg Hurrell
The newest research into fighting a virus that devastated New Zealand’s multimillion-dollar Pacific oyster industry has global commercial potential despite its novel and “blue-sky nature”, scientists say.Nelson's independent Cawthron Institute has been granted $1 million over three years from the Endeavour Fund to develop a practical vaccine for Pacific oyster mortality syndrome (Poms), a goal previously thought impossible for shellfish.The Ministry of Business, Innovation and Employment (MBIE) administers the fund.The gra...

More Primary Sector

Global meat demand surges, but NZ’s supply is lagging
Primary Sector

Global meat demand surges, but NZ’s supply is lagging

It could be costing NZ hundreds of millions of dollars in lost export revenue.

NZ meat sector warns: Get on board or lose out
Primary Sector

NZ meat sector warns: Get on board or lose out

The EU's deforestation rules could result in a $200 million hit.

AgriZeroNZ invests $6.3m in US biotech BiomEdit
Primary Sector

AgriZeroNZ invests $6.3m in US biotech BiomEdit

It's probiotic-based feed additive is dairy cow's productivity and cut emissions.

Riley Kennedy 22 Jul 2025
Grass-fed boost to NZ’s China brand 'significant opportunity'
Primary Sector

Grass-fed boost to NZ’s China brand 'significant opportunity'

Zespri wants to double its business in the country in the next 10 years.

Riley Kennedy 21 Jul 2025